By John Q. Hosedrinker 
The Trump administration abruptly halted NIH grant review panels and imposed a broad communication blackout across HHS, impacting agencies like the NIH, FDA, and CDC. This pause affects billions of dollars in research funding, delaying crucial studies on diverse topics ranging from cancer to the opioid crisis. The disruption also includes the suspension of advisory council meetings, further hindering the approval of new research grants. Researchers express deep concern about the impact on scientific progress, the loss of valuable expertise, and the potential negative consequences for patient care. The long-term effects of this freeze remain uncertain, but significant delays and a chilling effect on scientific endeavors are anticipated.
Read the original article here
What the hell is going on at NIH? The situation is alarming; a sweeping crackdown on research funding is underway, and scientists are sounding the alarm. This isn’t just about impacting ongoing projects; it’s a systematic dismantling of the very foundations of scientific advancement in the United States.
All grant reviews at the NIH have been canceled. This immediate freeze might seem like a short-term pause, but its consequences are far-reaching and could cripple research labs struggling to maintain basic operations. The longer this continues, the greater the risk of labs becoming unable to pay for essential supplies and equipment.
The ramifications extend far beyond the laboratories themselves. Graduate students and postdoctoral researchers, the future leaders in scientific research, depend heavily on NIH grants for their training and careers. Many prestigious grants, essential for funding and career advancement, are specifically earmarked for US citizens and are now in jeopardy. The disruption threatens the training pipeline, jeopardizing America’s position at the forefront of global scientific research.
This isn’t just about basic research; it’s about medical research impacting public health. This includes research into diseases like cancer, which directly affects the well-being of the American population. The consequences of these funding freezes will be felt for years to come. The suggestion that this stems from the administration’s negative perception of COVID-19 testing reveals a concerning disregard for science and public health.
It’s not solely about NIH-funded research. Similar concerns are being raised in other fields, like renewable energy research at the National Renewable Energy Laboratory (NREL). Research projects that contradict the administration’s agenda are facing censorship, termination, or outright deletion, creating a chilling effect on scientific inquiry.
The freeze on funding is being used as a tool for power consolidation. The administration is leveraging this financial control over government agencies and organizations that rely on US funding, such as the WHO and NATO. By controlling funding and information, the executive branch can exert unprecedented influence without needing new legislation or public record. The message is clear: comply or lose funding.
The situation has some viewing this as a blatant move towards fascism, where the fight transcends traditional political divides. It’s framed as a battle between the working class and the elite, with other conflicts seen as mere distractions. The anger and frustration are palpable.
The implications are vast. The disruption extends beyond medical research, impacting crucial resources like comprehensive free journal libraries used across many scientific disciplines. The consequences for the advancement of knowledge could be catastrophic. This is a systematic attempt to undermine the very principles that the United States was founded upon: progress and the betterment of its people.
The concern isn’t merely hypothetical. Researchers are losing funding, positions are disappearing, and the morale within the scientific community is plummeting. The cancellation of meetings and applications puts already precarious research projects at severe risk. The future of research programs is uncertain, affecting both the scientists involved and the potential benefits for society. The impact on individuals with terminal illnesses participating in crucial clinical trials is particularly devastating.
This isn’t a new phenomenon. There’s documented history of attempts to restrict research funding and suppress scientific findings that don’t align with a specific agenda. The current situation is seen as a calculated attempt to stifle critical thinking and maintain a narrative that prioritizes blind faith over evidence-based decision-making.
The magnitude of the problem is significant. It’s not just about disrupting research; it’s about dismantling an entire system. This extends to the FDA, the VA healthcare system, and even affects the collection and dissemination of important data regarding economic trends. The longer-term economic ramifications could be far-reaching and profoundly negative. The only anticipated beneficiaries seem to be those with significant financial resources capable of acquiring assets at deeply discounted prices.
The situation is not just alarming; it’s deeply concerning for the future of science, public health, and the very fabric of democratic society. This is not about political differences, but about the very survival of the American scientific enterprise and the well-being of its people. The silence surrounding this issue is dangerous and underscores the severity of the ongoing threat.